What is not required on a prescription for C2 drugs prescribed by an RPA?

The requirement for a prescription for Schedule II (C2) drugs prescribed by a Registered Physician Assistant (RPA) includes specific elements that must be present to ensure legality and compliance with regulatory standards.

In this case, the supervising physician's address is not a mandated element on the prescription. While the supervising physician plays a crucial role in the oversight of the RPA's practice, regulations typically focus on the RPA's qualifications and details that directly relate to the prescription and patient.

Conversely, the patient's address is a necessary component as it helps with identifying the patient and ensuring appropriate dispensing of the medication. Additionally, the RPA's signature is required to authenticate the prescription, demonstrating that the RPA authorized the medication. The DEA number of the supervising physician is essential as it indicates that the prescribing authority is legitimate and that the physician is registered to prescribe controlled substances.

Thus, the omission of the supervising physician's address from the prescription reflects that it is not a regulatory requirement, emphasizing the importance of the RPA's direct prescribing information and connections to legal prescribing practices.